INTRODUCTION {#sec1-1}
============

Sustained ventricular tachycardia (VT) is rare in infancy. We report a case of incessant drug-refractory fascicular VT in an 8-month-old infant presenting with heart failure and severe left ventricular (LV) systolic dysfunction. Catheter ablation resulted in the termination of VT and reversal of LV function.

CASE REPORT {#sec1-2}
===========

An 8-month-old male infant weighing 7.7 kg was referred with the diagnosis of VT and LV dysfunction. The infant presented with a history of poor oral intake and breathing difficulty of 1-week duration. There was no history of fever and no clinical or laboratory evidence of systemic infection. He was treated initially with tablet diltiazem (1 mg/kg/dose eight hourly) and subsequently with amiodarone infusion (up to 15 mcg/kg/min) with no response. At the time of admission to our unit, the heart rate was 200/min, with low-volume pulses and mean blood pressure of 40 mmHg. There were palpable congestive hepatomegaly and LV S3 with a gallop. Chest X-ray showed a Cardio-Thoracic ratio of 0.65 and pulmonary venous congestion. Echocardiography revealed a severe LV systolic dysfunction (LV ejection fraction \[EF\]: 30%). Electrocardiography showed a ventricular rate of 200/min, relatively narrow QRS complexes with right bundle branch block (RBBB) morphology, right axis deviation, and Ventriculo-Atrial (V-A) Dissociation suggestive of fascicular VT \[[Figure 1](#F1){ref-type="fig"}\]. A diagnosis of tachycardiomyopathy due to incessant fascicular VT was made. He was started on inotropic support and diuretics. Electrical cardioversion was tried multiple times with a dose of 2 J/kg without any success. Intravenous verapamil with a dose of 0.1--0.2 mg/kg followed by 5 mcg/kg/min and xylocard were tried without any response. In view of incessant VT unresponsive to drugs and cardioversion, radiofrequency ablation was planned. After taking informed consent from the parents, ablation was successfully performed with no further recurrence of VT. Infant improved symptomatically, and EF normalized after ablation and discharged in a stable condition. The child has not had a recurrence at 2 years of follow-up and is off medications.

![12 Lead ECG of the patient showing Fascicular VT](APC-13-153-g001){#F1}

Details of ablation procedure {#sec2-1}
-----------------------------

The child was brought into the electrophysiology laboratory in incessant VT, with RBBB morphology, left superior, and relatively narrow QRS with VA dissociation \[[Figure 1](#F1){ref-type="fig"}\]. The procedure was done under controlled general anesthesia. Vascular access was obtained through the right femoral vein and artery and the right internal jugular vein. Catheters were placed in the coronary sinus, His bundle region and single catheter in right ventricle (RV) & Right atrium (not shown in figure). Heparin bolus of 100u/kg was administered, and activated clotting time (ACT) was maintained consistently over 300 s with repetitive heparin boluses. By retrograde approach, a 5Fr mapping catheter (nonirrigated Biosense Webster) was introduced into the left ventricle \[[Figure 2](#F2){ref-type="fig"}\]. Careful mapping of the posterior LV septum was done to identify the earliest Purkinje potential (PP). Earliest PP preceded QRS by 40 ms. This area was carefully mapped to identify pre-PP or diastolic potentials \[[Figure 3](#F3){ref-type="fig"}\]. Concealed entrainment with a postpacing interval-tachycardia cycle length of \<10 ms was demonstrated. The delivery of radiofrequency lesion of 55 watts at 55°C, almost immediately terminated tachycardia \[[Figure 4](#F4){ref-type="fig"}\]. Lesions linearly were delivered both apically and basally. Postablation sinus rhythm was restored. Programmed electrical stimulation with single and double extrastimuli from RV and LV, and burst pacing from RV and LV did not induce tachycardia. The protocol was repeated with isoprenaline infusion without inducing VT. No further recurrence of VT occurred.

![Fluoroscopy position of catheters in shallow left oblique view (LAO) view](APC-13-153-g002){#F2}

![Electrophysiological Tracing showing Purkinje potentials](APC-13-153-g003){#F3}

![Sinus Rhythm after Radiofrequency Ablation](APC-13-153-g004){#F4}

DISCUSSION {#sec1-3}
==========

Ventricular arrhythmia causing hemodynamic instability is rare in infantile age and usually secondary to structural and metabolic problems.\[[@ref1][@ref2][@ref3]\] Ventricular arrhythmia with structurally normal heart is generally well tolerated and is usually focal, mostly from the RV outflow tract, left ventricular outflow tract/sinus of Valsalva, mitral valve annulus, and tricuspid valve annulus.\[[@ref4][@ref5]\] Another type of VT occurring in structurally normal heart is fascicular VT due to re-entry at or near fascicle on the left side referred to as idiopathic LV tachycardia (ILVT). Most of the ILVT are verapamil sensitive and this drug can be used safely in infancy for treatment.\[[@ref6]\] In view of narrow QRS complexes, they are often misdiagnosed as supraventricular tachycardia (SVT), and sometimes, a lack of response to IV adenosine is a clue to the diagnosis. Tachycardia with RBBB, left axis deviation, and relatively narrow QRS complexes (but wider as compared to sinus) is characteristic of ILVT. If present AV dissociation and capture beats also add in differentiating it from SVT. Medical therapy is recommended as the first line of treatment with calcium channel blocker -- verapamil being the drug of choice. RF ablation is considered as a class I indication for recurrent or persistent symptomatic tachyarrhythmia, or VT with hemodynamic compromise when medical therapy is either not effective or is associated with intolerable adverse effects or as an alternative to medical therapy.\[[@ref1]\]

However, studies suggested ablation in children should be deferred until the child weighs ≥15 kg.\[[@ref7][@ref8]\] However, no difference is observed in the success rate in small children for eliminating arrhythmias in comparison to older children.\[[@ref9][@ref10]\] It may be partially due to the fact that ablations in smaller children are likely to be attempted by more experienced pediatric electrophysiologists, and experience has been shown to be an important factor in successful radiofrequency ablation (RFA) procedures.\[[@ref9]\] It is challenging to differentiate tachycardia presenting with ventricular dysfunction (tachycardiomyopathy) from primary dilated cardiomyopathy producing tachycardia.\[[@ref10]\] This differentiation is crucial as ventricular dysfunction secondary to tachycardia is reversible. The presence of a monomorphic VT of single morphology with LV dysfunction suggests tachycardiomyopathy.

We were faced with a situation where an infant presented with heart failure and hemodynamically unstable incessant fascicular VT refractory to drugs and cardioversion. Ablation was the only therapeutic option at that stage. Cardiac magnetic resonance imaging would have been a useful tool to exclude myocarditis but was not feasible in view of the clinical situation. We did not use three-dimensional mapping to avoid using large-caliber (8F) sheaths. Mapping and ablation were done with a smaller caliber 5F catheter. This report highlights the feasibility and importance of applying the therapeutic modality of RFA as a life-saving measure even in very young patients with incessant VT.

RFA is not commonly done in infancy in view of the potential response of arrhythmias to medications, difficulty in the availability of appropriate hardware and concern for complications. There are few reports of the use of catheter ablation for VT in infants with good outcomes.\[[@ref2][@ref8][@ref9][@ref10]\] To the best of our knowledge, this is the youngest infant in the literature who underwent successful RFA for incessant fascicular VT.

CONCLUSION {#sec1-4}
==========

Catheter ablation can be used as a lifesaving procedure in infants with incessant fascicular VT and heart failure.
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